{
    "Trade/Device Name(s)": [
        "AP-3000 Blood Glucose Monitoring System",
        "AP-3000multi Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bestgen Biotech Corporation",
    "510(k) Number": "K103230",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090389"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "April 19, 2012",
    "Summary Letter Received Date": "April 23, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AP-3000 Meter",
        "AP-3000multi Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometry",
        "Glucose oxidase (Aspergillus niger)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Meter",
        "Test Strip",
        "Quality Control Material"
    ],
    "Document Summary": "FDA 510(k) summary for AP-3000 and AP-3000multi Blood Glucose Monitoring Systems for quantitative glucose measurement and monitoring in persons with diabetes",
    "Indications for Use Summary": "Intended for quantitative measurement and monitoring of glucose in persons with diabetes at home (AP-3000) or multiple users (AP-3000multi); not for diagnosis or screening of diabetes mellitus and not for neonatal use; includes quality control materials for test accuracy verification",
    "fda_folder": "Clinical Chemistry"
}